£77.10

Springer Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Price data last checked 32 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£77 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 59 days • 59 data points (No recent data available)

Historical
Generating forecast...
£77.89 £77.02 £77.21 £77.40 £77.59 £77.78 £77.97 28 March 2026 11 April 2026 26 April 2026 10 May 2026 25 May 2026

Price Distribution

Price distribution over 59 days • 2 price levels

Days at Price
Current Price
20 days · current 39 days 0 10 20 29 39 £77 £78 Days at Price

Price Analysis

Most common price: £78 (39 days, 66.1%)

Price range: £77 - £78

Price levels: 2 different prices over 59 days

Description

This book reviews the main neurobiological, neurophysiological, MRI and clinical features of the early phases of MS. Mechanisms of irreversible axonal damage and the role played by the interaction between glial and axons are highlighted. Contrary to what was thought for a long time the sufficient availability of oligodendrocyte precursor cells to promote remyelination in acute lesions has now been demonstrated. For not understood reasons, remyelination process fails or does not start in many cases, particularly, in the chronic process of the disease. These findings express the importance of the milieu changes induced by inflammatory process in limiting remyelination. Pathological studies demonstrate that in MS destructive processes may be followed by recovering phases in such a way that myelin may be morphologically and functionally reconstructed. This all brings the rationale of early treatments and the results of clinical trials in early MS to the fore as one of the most important questions today.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
28 September 2012
Listed Since
06 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments
86% match

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments

Springer

£81.58 25 May 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
86% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£142.27 04 Jun 2026
Multiple Sclerosis: Practical Comprehensive Essentials
86% match

Multiple Sclerosis: Practical Comprehensive Essentials

£75.00 12 Jun 2026
From Basic Immunology to Immune-Mediated Demyelination (Topics in Neuroscience)
85% match

From Basic Immunology to Immune-Mediated Demyelination (Topics in Neuroscience)

Springer

£142.46 19 May 2026
Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)
84% match

Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)

Springer

£107.98 18 May 2026
Multiple Sclerosis: Diagnosis and Therapy
83% match

Multiple Sclerosis: Diagnosis and Therapy

Wiley-Blackwell

£72.62 14 May 2026
Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)
83% match

Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)

Springer

£109.24 10 Jun 2026
Molecular Biology of Multiple Sclerosis
83% match

Molecular Biology of Multiple Sclerosis

Wiley-Blackwell

£135.00 16 May 2026
MRI Atlas of MS Lesions
82% match

MRI Atlas of MS Lesions

Springer

£80.64 10 Jun 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
81% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 11 Jun 2026
Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity
81% match

Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity

Springer

£107.98 31 May 2026
Neuron-Glia Interaction in Neuroinflammation: 7 (Advances in Neurobiology, 7)
81% match

Neuron-Glia Interaction in Neuroinflammation: 7 (Advances in Neurobiology, 7)

Springer

£123.63 31 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
80% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£108.75 14 Jun 2026
Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)
80% match

Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)

Elsevier

£65.96 25 May 2026
Neurodegenerative Disorders: A Clinical Guide
80% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 26 May 2026
80% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Academic Press

£137.99 20 May 2026
Neuroimmunology (Current Topics in Neurobiology)
79% match

Neuroimmunology (Current Topics in Neurobiology)

Springer

£77.86 25 May 2026
Schwann Cell Development and Pathology
79% match

Schwann Cell Development and Pathology

Springer

£80.64 26 May 2026
MR Imaging and Spectroscopy of Central Nervous System Infection
79% match

MR Imaging and Spectroscopy of Central Nervous System Infection

Springer

£113.76 31 May 2026
Protective and Pathological Immune Responses in the CNS: 265 (Current Topics in Microbiology and Immunology, 265)
79% match

Protective and Pathological Immune Responses in the CNS: 265 (Current Topics in Microbiology and Immunology, 265)

Springer

£107.98 21 May 2026
Therapeutic rTMS in Neurology: Principles, Evidence, and Practice Recommendations
79% match

Therapeutic rTMS in Neurology: Principles, Evidence, and Practice Recommendations

Springer

£95.70 16 May 2026
Neurological Disorders and Pregnancy
79% match

Neurological Disorders and Pregnancy

Elsevier

£110.00 12 Jun 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
78% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Metals and Oxidative Damage in Neurological Disorders
78% match

Metals and Oxidative Damage in Neurological Disorders

Springer

£143.38 29 May 2026